Synthesis 1994; 1994(9): 965-968
DOI: 10.1055/s-1994-25615
paper
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Synthesis of 4-Methoxy-N-{2-[3-(Methylamino)heptyl]phenyl}benzamide, an Antiarrhythmic Compound Related to Encainide

Michael D. Thompson* , Houshang Torabi
  • *Chemical Process Development, Bristol-Myers Squibb, Co., Evansville, Indiana 47721, USA
Further Information

Publication History

Publication Date:
17 September 2002 (online)

A ring-opened side product 3, formed during the reduction of a pyridinium precursor to the antiarrhythmic drug, encainide (2), was isolated. The structure of 3 was confirmed by an independent synthesis from o-iodonitrobenzene and 1-hepten-3-ol. The key step was a palladium(II) catalyzed coupling to introduce the 3-oxoheptyl side chain onto the aromatic ring. Synthetic 3 exhibited significant antiarrhythmic activity.